Network+ Industry partner Ithera Medical have recently had work published in the New England Medical Journal in collaboration with the University of Erlangen.

The accurate assessment of Crohn’s disease severity and effect of therapy currently involves an invasive endoscopy procedure. In this study the clinicians used the Ithera Medical clinical MSOT system to stage the severity of the inflammatory response in Crohn’s disease patients by a non-invasive transabdominal procedure and this correlated to a high degree with the endoscopy findings.

Read the full paper here.